Short-read Sequencing Market Size, Share and Growth Outlook 2026: By Offering (Product and Services) (Instruments, Consumables, Services), By Platform Technology, By Application, By End User, Companies to 2034.
The global Short-read Sequencing Market size is forecast to increase from $7.1 Billion in 2026 to $26.13 Billion in 2034 at a CAGR of 17.69% between 2026 and 2034.
The Short-read Sequencing market report provides detailed analysis and outlook of Short-read Sequencing segments including By Offering (Product and Services) (Instruments, Consumables, Services), By Platform Technology (Sequencing by Synthesis (SBS), Sequencing by Binding (SBB), Sequencing by Ligation (SBL)), By Application (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing and Gene Panels), By End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research and Diagnostic Laboratories) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Short-read Sequencing Industry Overview
Spatial Biology, Multiomics, and Clinical Genomics Are Expanding the Capabilities of Short-Read Sequencing
The short-read sequencing industry is undergoing a major technological transformation as traditional DNA sequencing platforms evolve into integrated multiomic and spatial biology ecosystems. While short-read sequencing remains the foundational technology for genomics, transcriptomics, liquid biopsy testing, and precision medicine, manufacturers are increasingly extending these platforms into spatial transcriptomics, epigenomics, and in situ molecular profiling applications. Growing demand for high-throughput biomarker discovery, minimal residual disease monitoring, translational oncology research, and multiomic characterization is driving investment in advanced chemistries, automated workflows, and artificial intelligence-enabled analytical pipelines. These developments are reinforcing short-read sequencing as a central analytical infrastructure for both research and clinical diagnostics.
Spatial Transcriptomics and In Situ Sequencing Are Redefining Molecular Profiling
One of the most important developments in the short-read sequencing market is the convergence of sequencing technologies with spatial biology workflows. Supporting this transition, Singular Genomics launched the G4X™ Spatial Sequencer, utilizing proprietary Direct-Seq™ in situ chemistry to directly interrogate transcriptomic information, fluorescent histology morphology, and immune receptor clonotypes within formalin-fixed paraffin-embedded tissue sections. This architecture enables simultaneous spatial and molecular characterization of tumor microenvironments while supporting high-throughput translational medicine applications. Similarly, Illumina expanded its spatial biology portfolio through the commercial launch of the StrataMap™ Spatial Solution, providing an automated whole-transcriptome workflow designed for scalable spatial analysis across benchtop sequencing systems.
Multiomic Integration and Advanced Bioinformatics Are Accelerating Precision Medicine Applications
The short-read sequencing industry is also advancing through improvements in computational biology, epigenomic profiling, and integrated multiomic analysis. Illumina strengthened its bioinformatics ecosystem with the deployment of DRAGEN v4.5 software, enabling analysis of simultaneous genomic and methylomic profiles through its emerging 5-base sequencing assays while enhancing sensitivity for minimal residual disease liquid biopsy workflows on NovaSeq X systems. Concurrently, Element Biosciences expanded the capabilities of its AVITI24™ platform through the introduction of Direct In Sample Sequencing consumables that bypass conventional library preparation workflows by directly profiling molecular architecture within intact biological samples. By enabling simultaneous cell profiling and targeted transcript quantification on a single flow cell, these innovations support increasingly sophisticated applications in neonatal research, precision oncology, and multiomic biomarker discovery, highlighting the industry's transition toward fully integrated molecular characterization platforms.
Short-read Sequencing Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Short-read Sequencing market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Illumina, Inc., Complete Genomics (MGI Tech), Thermo Fisher Scientific Inc., QIAGEN N.V., BGI Group, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Pacific Biosciences, PerkinElmer, Inc., Bio-Rad Laboratories, Inc.. The Short-read Sequencing market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Short-read Sequencing industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Short-read Sequencing industry include- Illumina, Inc., Complete Genomics (MGI Tech), Thermo Fisher Scientific Inc., QIAGEN N.V., BGI Group, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Pacific Biosciences, PerkinElmer, Inc., Bio-Rad Laboratories, Inc.. The Short-read Sequencing market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Short-read Sequencing Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Short-read Sequencing market remains one of the strongest-performing segments in the country.
The US Short-read Sequencing Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Short-read Sequencing market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Short-read Sequencing industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Short-read Sequencing markets
Canada's strong Short-read Sequencing sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Short-read Sequencing market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Short-read Sequencing Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Short-read Sequencing market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Short-read Sequencing population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Short-read Sequencing industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Short-read Sequencing market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Short-read Sequencing sales through 2034
France Short-read Sequencing companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Short-read Sequencing Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Short-read Sequencing distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Short-read Sequencing Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Short-read Sequencing market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Short-read Sequencing industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Short-read Sequencing industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Short-read Sequencing Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Short-read Sequencing market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Short-read Sequencing market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Short-read Sequencing Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Short-read Sequencing Market Segmentation
By Offering (Product and Services)
Instruments
Consumables
Services
By Platform Technology
Sequencing by Synthesis (SBS)
Sequencing by Binding (SBB)
Sequencing by Ligation (SBL)
By Application
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Targeted Sequencing and Gene Panels
By End User
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Clinical Research and Diagnostic Laboratories
Leading Companies in Short-read Sequencing Industry (2026)
Illumina, Inc.
Complete Genomics (MGI Tech)
Thermo Fisher Scientific Inc.
QIAGEN N.V.
BGI Group
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
Pacific Biosciences
PerkinElmer, Inc.
Bio-Rad Laboratories, Inc.
Countries Included
The Short-read Sequencing market report provides detailed analysis and outlook of Short-read Sequencing segments including By Offering (Product and Services) (Instruments, Consumables, Services), By Platform Technology (Sequencing by Synthesis (SBS), Sequencing by Binding (SBB), Sequencing by Ligation (SBL)), By Application (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing and Gene Panels), By End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research and Diagnostic Laboratories) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Short-read Sequencing Industry Overview
Spatial Biology, Multiomics, and Clinical Genomics Are Expanding the Capabilities of Short-Read Sequencing
The short-read sequencing industry is undergoing a major technological transformation as traditional DNA sequencing platforms evolve into integrated multiomic and spatial biology ecosystems. While short-read sequencing remains the foundational technology for genomics, transcriptomics, liquid biopsy testing, and precision medicine, manufacturers are increasingly extending these platforms into spatial transcriptomics, epigenomics, and in situ molecular profiling applications. Growing demand for high-throughput biomarker discovery, minimal residual disease monitoring, translational oncology research, and multiomic characterization is driving investment in advanced chemistries, automated workflows, and artificial intelligence-enabled analytical pipelines. These developments are reinforcing short-read sequencing as a central analytical infrastructure for both research and clinical diagnostics.
Spatial Transcriptomics and In Situ Sequencing Are Redefining Molecular Profiling
One of the most important developments in the short-read sequencing market is the convergence of sequencing technologies with spatial biology workflows. Supporting this transition, Singular Genomics launched the G4X™ Spatial Sequencer, utilizing proprietary Direct-Seq™ in situ chemistry to directly interrogate transcriptomic information, fluorescent histology morphology, and immune receptor clonotypes within formalin-fixed paraffin-embedded tissue sections. This architecture enables simultaneous spatial and molecular characterization of tumor microenvironments while supporting high-throughput translational medicine applications. Similarly, Illumina expanded its spatial biology portfolio through the commercial launch of the StrataMap™ Spatial Solution, providing an automated whole-transcriptome workflow designed for scalable spatial analysis across benchtop sequencing systems.
Multiomic Integration and Advanced Bioinformatics Are Accelerating Precision Medicine Applications
The short-read sequencing industry is also advancing through improvements in computational biology, epigenomic profiling, and integrated multiomic analysis. Illumina strengthened its bioinformatics ecosystem with the deployment of DRAGEN v4.5 software, enabling analysis of simultaneous genomic and methylomic profiles through its emerging 5-base sequencing assays while enhancing sensitivity for minimal residual disease liquid biopsy workflows on NovaSeq X systems. Concurrently, Element Biosciences expanded the capabilities of its AVITI24™ platform through the introduction of Direct In Sample Sequencing consumables that bypass conventional library preparation workflows by directly profiling molecular architecture within intact biological samples. By enabling simultaneous cell profiling and targeted transcript quantification on a single flow cell, these innovations support increasingly sophisticated applications in neonatal research, precision oncology, and multiomic biomarker discovery, highlighting the industry's transition toward fully integrated molecular characterization platforms.
Short-read Sequencing Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Short-read Sequencing market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Illumina, Inc., Complete Genomics (MGI Tech), Thermo Fisher Scientific Inc., QIAGEN N.V., BGI Group, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Pacific Biosciences, PerkinElmer, Inc., Bio-Rad Laboratories, Inc.. The Short-read Sequencing market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Short-read Sequencing industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Short-read Sequencing Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Short-read Sequencing companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Short-read Sequencing markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Short-read Sequencing industry include- Illumina, Inc., Complete Genomics (MGI Tech), Thermo Fisher Scientific Inc., QIAGEN N.V., BGI Group, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Pacific Biosciences, PerkinElmer, Inc., Bio-Rad Laboratories, Inc.. The Short-read Sequencing market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Short-read Sequencing Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Short-read Sequencing market remains one of the strongest-performing segments in the country.
The US Short-read Sequencing Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Short-read Sequencing market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Short-read Sequencing industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Short-read Sequencing markets
Canada's strong Short-read Sequencing sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Short-read Sequencing market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Short-read Sequencing Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Short-read Sequencing market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Short-read Sequencing population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Short-read Sequencing industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Short-read Sequencing market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Short-read Sequencing sales through 2034
France Short-read Sequencing companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Short-read Sequencing Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Short-read Sequencing distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Short-read Sequencing Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Short-read Sequencing market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Short-read Sequencing industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Short-read Sequencing industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Short-read Sequencing Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Short-read Sequencing market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Short-read Sequencing market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Short-read Sequencing Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Short-read Sequencing Market Segmentation
By Offering (Product and Services)
Instruments
Consumables
Services
By Platform Technology
Sequencing by Synthesis (SBS)
Sequencing by Binding (SBB)
Sequencing by Ligation (SBL)
By Application
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Targeted Sequencing and Gene Panels
By End User
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Clinical Research and Diagnostic Laboratories
Leading Companies in Short-read Sequencing Industry (2026)
Illumina, Inc.
Complete Genomics (MGI Tech)
Thermo Fisher Scientific Inc.
QIAGEN N.V.
BGI Group
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
Pacific Biosciences
PerkinElmer, Inc.
Bio-Rad Laboratories, Inc.
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Short-read Sequencing Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Short-read Sequencing Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL SHORT-READ SEQUENCING MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Short-read Sequencing Markets in 2026
3.2. Global Historic and Forecast Short-read Sequencing Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Short-read Sequencing Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Short-read Sequencing Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Short-read Sequencing Value Chain
CHAPTER 4- SHORT-READ SEQUENCING MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Short-read Sequencing Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- SHORT-READ SEQUENCING MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Offering (Product and Services)
Instruments
Consumables
Services
By Platform Technology
Sequencing by Synthesis (SBS)
Sequencing by Binding (SBB)
Sequencing by Ligation (SBL)
By Application
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Targeted Sequencing and Gene Panels
By End User
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Clinical Research and Diagnostic Laboratories
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Short-read Sequencing Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Short-read Sequencing Market Trends and Growth Opportunities to 2034
7.5. North America Short-read Sequencing Market Size Outlook by Type
7.6. North America Short-read Sequencing Market Size Outlook by Application
7.7. North America Short-read Sequencing Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Short-read Sequencing Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Short-read Sequencing Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Short-read Sequencing Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Short-read Sequencing Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Short-read Sequencing Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Short-read Sequencing Companies
CHAPTER 8- EUROPE SHORT-READ SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Short-read Sequencing Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Short-read Sequencing Market Trends and Growth Opportunities to 2034
8.5. Europe Short-read Sequencing Market Size Outlook by Type
8.6. Europe Short-read Sequencing Market Size Outlook by Application
8.7. Europe Short-read Sequencing Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Short-read Sequencing Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Short-read Sequencing Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Short-read Sequencing Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Short-read Sequencing Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Short-read Sequencing Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Short-read Sequencing Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Short-read Sequencing Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Short-read Sequencing Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Short-read Sequencing Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Short-read Sequencing Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Short-read Sequencing Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Short-read Sequencing Companies
CHAPTER 9- ASIA PACIFIC SHORT-READ SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Short-read Sequencing Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Short-read Sequencing Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Short-read Sequencing Market Size Outlook by Type
9.6. Asia Pacific Short-read Sequencing Market Size Outlook by Application
9.7. Asia Pacific Short-read Sequencing Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Short-read Sequencing Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Short-read Sequencing Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Short-read Sequencing Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Short-read Sequencing Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Short-read Sequencing Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Short-read Sequencing Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Short-read Sequencing Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Short-read Sequencing Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Short-read Sequencing Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Short-read Sequencing Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Short-read Sequencing Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Short-read Sequencing Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA SHORT-READ SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Short-read Sequencing Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Short-read Sequencing Market Trends and Growth Opportunities to 2034
10.5. South and Central America Short-read Sequencing Market Size Outlook by Type
10.6. South and Central America Short-read Sequencing Market Size Outlook by Application
10.7. South and Central America Short-read Sequencing Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Short-read Sequencing Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Short-read Sequencing Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Short-read Sequencing Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Short-read Sequencing Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Short-read Sequencing Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Short-read Sequencing Companies
CHAPTER 11- MIDDLE EAST AND AFRICA SHORT-READ SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Short-read Sequencing Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Short-read Sequencing Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Short-read Sequencing Market Size Outlook by Type
11.6. Middle East and Africa Short-read Sequencing Market Size Outlook by Application
11.7. Middle East and Africa Short-read Sequencing Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Short-read Sequencing Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Short-read Sequencing Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Short-read Sequencing Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Short-read Sequencing Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Short-read Sequencing Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Short-read Sequencing Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Short-read Sequencing Industry
Illumina, Inc.
Complete Genomics (MGI Tech)
Thermo Fisher Scientific Inc.
QIAGEN N.V.
BGI Group
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
Pacific Biosciences
PerkinElmer, Inc.
Bio-Rad Laboratories, Inc.
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Short-read Sequencing Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Short-read Sequencing Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL SHORT-READ SEQUENCING MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Short-read Sequencing Markets in 2026
3.2. Global Historic and Forecast Short-read Sequencing Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Short-read Sequencing Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Short-read Sequencing Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Short-read Sequencing Value Chain
CHAPTER 4- SHORT-READ SEQUENCING MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Short-read Sequencing Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- SHORT-READ SEQUENCING MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Offering (Product and Services)
Instruments
Consumables
Services
By Platform Technology
Sequencing by Synthesis (SBS)
Sequencing by Binding (SBB)
Sequencing by Ligation (SBL)
By Application
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Targeted Sequencing and Gene Panels
By End User
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Clinical Research and Diagnostic Laboratories
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Short-read Sequencing Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Short-read Sequencing Market Trends and Growth Opportunities to 2034
7.5. North America Short-read Sequencing Market Size Outlook by Type
7.6. North America Short-read Sequencing Market Size Outlook by Application
7.7. North America Short-read Sequencing Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Short-read Sequencing Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Short-read Sequencing Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Short-read Sequencing Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Short-read Sequencing Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Short-read Sequencing Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Short-read Sequencing Companies
CHAPTER 8- EUROPE SHORT-READ SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Short-read Sequencing Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Short-read Sequencing Market Trends and Growth Opportunities to 2034
8.5. Europe Short-read Sequencing Market Size Outlook by Type
8.6. Europe Short-read Sequencing Market Size Outlook by Application
8.7. Europe Short-read Sequencing Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Short-read Sequencing Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Short-read Sequencing Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Short-read Sequencing Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Short-read Sequencing Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Short-read Sequencing Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Short-read Sequencing Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Short-read Sequencing Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Short-read Sequencing Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Short-read Sequencing Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Short-read Sequencing Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Short-read Sequencing Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Short-read Sequencing Companies
CHAPTER 9- ASIA PACIFIC SHORT-READ SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Short-read Sequencing Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Short-read Sequencing Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Short-read Sequencing Market Size Outlook by Type
9.6. Asia Pacific Short-read Sequencing Market Size Outlook by Application
9.7. Asia Pacific Short-read Sequencing Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Short-read Sequencing Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Short-read Sequencing Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Short-read Sequencing Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Short-read Sequencing Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Short-read Sequencing Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Short-read Sequencing Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Short-read Sequencing Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Short-read Sequencing Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Short-read Sequencing Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Short-read Sequencing Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Short-read Sequencing Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Short-read Sequencing Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA SHORT-READ SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Short-read Sequencing Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Short-read Sequencing Market Trends and Growth Opportunities to 2034
10.5. South and Central America Short-read Sequencing Market Size Outlook by Type
10.6. South and Central America Short-read Sequencing Market Size Outlook by Application
10.7. South and Central America Short-read Sequencing Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Short-read Sequencing Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Short-read Sequencing Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Short-read Sequencing Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Short-read Sequencing Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Short-read Sequencing Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Short-read Sequencing Companies
CHAPTER 11- MIDDLE EAST AND AFRICA SHORT-READ SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Short-read Sequencing Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Short-read Sequencing Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Short-read Sequencing Market Size Outlook by Type
11.6. Middle East and Africa Short-read Sequencing Market Size Outlook by Application
11.7. Middle East and Africa Short-read Sequencing Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Short-read Sequencing Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Short-read Sequencing Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Short-read Sequencing Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Short-read Sequencing Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Short-read Sequencing Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Short-read Sequencing Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Short-read Sequencing Industry
Illumina, Inc.
Complete Genomics (MGI Tech)
Thermo Fisher Scientific Inc.
QIAGEN N.V.
BGI Group
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
Pacific Biosciences
PerkinElmer, Inc.
Bio-Rad Laboratories, Inc.
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
